Designed to operate over public and private LTE and 5G networks, enabling full-duplex wireless intercom across wide ...
KEYNOTE-564 follow-up shows OS and DFS gains with adjuvant pembrolizumab in high-risk ccRCC, plus guidance on relapse after therapy. In the adjuvant setting, managing the patient with high-risk clear ...
Clear-Com has announced FreeSpeak Cell, a cellular-based wireless intercom system that uses LTE and 5G infrastructure to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results